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The Friend virus (FV)' and Rauscher leukemia virus (RV) complexes are unique
among the murine leukemia viruses (MuLV) in that they contain a rapidly acting,
erythroid leukemia-inducing, spleen focus-forming virus (SFFV) . Both the Friend and
Rauscher strains of SFFV are defective for spleen focus formation in vivo, are leukemo-
genic in susceptible adult mice, and can therefore be easily detected and quantified in
vivo (1,2) . However, early efforts to develop an in vitro assay for SFFV and to maintain
this virus in vitro have not been successful (3) . To date, the only in vitro source of Friend
SFFV has been FV-induced erythroleukemic spleen cells maintained in suspension
culture (4-6) . Virus obtained from these suspension cultures can be readily detected in
susceptible adult mice via the induction of spleen foci and erythroleukemia . More
recently, SFFV function has been successfully detected in vitro using a virus interference
test in conjunction with the XC cell plaque assay (7) .
Since it is now possible to detect SFFV function in vitro [i.e ., in mouse embryo
fibroblast (MEF) cultures], it was of interest to determine if SFFV could infect and
replicate in MEF cultures, and to what extent in vitro-grown SFFV maintained or lost
those biological properties normally ascribed to in vivo-maintained FV complex (i .e .,
SFFV-LLV) . In the FV and other leukemia virus systems, it has been noted that
extended in vitro growth in MEF is associated with "attenuation" of viral oncogenic
potential in vivo (8-13) . Only a recent study utilizing the Gross leukemia virus (GLV)
suggests that fully leukemogenic MuLV can be derived from monolayer cultures (14) .
However, the source of cells for these experiments was hyperplastic thymus tissue
obtained from 8-wk old GLV-infected C :IH mice . In contrast, I report in the present study
* This study was supported in part by grant no . VC-82 from The American Cancer Society, Inc.,
GRS grant no . 1425-5, and by NIH grants CA 15848 and 15369 .
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that both defective Friend SFFV and its associated LLV-F helper can productively infect
NIH Swiss MEF, and that virus stocks (SFFV and LLV-F) derived from this cell culture
system are fully leukemogenic in mice for the induction of erythroleukemia and lym-
phatic leukemia, respectively . SFFV contained in the in vitro-derived FV complex (here
referred to as FV-TC) has an NB-tropic host range (15) for the induction of foci in vivo . In
addition, FV-TC does not immunosuppress the responsiveness of murine lymphocytesto
concanavalin A (Con A) in vitro . Rather, FV-TC acts as a mitogen to nonspecifically
stimulate the proliferation of BALB/c thymocytes .
Materials and Methods
Mice .
￿
Male and female 4- to 6-wk old BALB/c, C3H/He, C57BL/6Ha, C58 waved, DBA/2Ha,
and 129 mice were obtained from our own breeding colony . In addition, ABT/Ha mice were
originally obtained through the courtesy of Dr .T . S . Hauschka, Roswell Park Memorial Institute,
Buffalo, N. Y. and are now maintained in our breeding colony . These highly inbred mice (>50
generations) are shown to be homozygous belted (bt) (16),H-2d , andFu2''' (17) .
Viruses . SFFV, as contained in theNB-tropic (15) strain ofFV complex, hadundergone 14 cell-
free passages in adult BALB/c mice when it wasused in an attempt to infectNIH Swiss MEF. The
isolation and maintenance of the LLV-F stocks used has been previously described (18) .
Virus Titration .
￿
AllSFFV preparations were titrated in fully susceptible adult mice with the
spleen focus assay method (19) . Virus titers were expressed in focus-forming units (FFU) per
milliliter . In addition, all preparations ofFV complex were titrated in BALB/c MEFusing theXC
plaque assay (20) . Plaques were counted macroscopically and also viewed microscopically for the
presence of syncytial giant cells . It was possible to obtain titer estimates in plaque-forming units
(PFU) per milliliter for LLV-F contained in the FV complex with SFFV . LLV-F is always present
in theFV complex 10- to 100-fold excess over SFFV . LLVcan thereforebe isolated free ofSFFV via
endpoint dilution techniques . We can therefore simultaneously determine the dose of both SFFV
(in FFU) and LLV-F (in PFU) given to a susceptible mouse or used as an inoculum for an XC
plaque assay .
Microplate Culture System for T-Cell Mitogens . FV preparations were tested for their ability
to either suppress the proliferative response of normal mouse lymphocytes to ConA in vitro or to
independently stimulate mouse thymocytes (i .e ., act as a nonspecific mitogen for T cells) as
follows : nucleated BALB/c thymus cells were cultured in Falcon Microtest II plates (Falcon
Plastics, Div . of BioQuest, Oxnard, Calif.) at 37°C for 3 days with either 1Ag of Con A, FV, or both .
Control cultures received neither the T-cell mitogen nor FV . 0.5 WCi of [3H]thymidine was used to
label proliferating cells synthesizing DNA, and the cell suspensions were harvested with a
Microbiological Associates MASH II automatic harvester (Bethesda, Md .) . The radioactivity in
filter discs was measured in a liquid scintillation counter . The mitogenic response of the cultured
T cells is presented in terms of the blastogenic index (BI) . The BI is defined as the ratio of the
result of the test culture to the corresponding control for mitogen response (cpm [3H]thymidine
with mitogen/cpm no mitogen) .
Results
Productive Infection ofSwissMEF byFriendSFFV .
￿
It has been established
that Friend LLV, like other MuLV's, can infect MEF and induce XC plaques (7) .
However, it has not been established if Friend SFFV can productively infect
MEF . The only hint that defective SFFV is infectious for MEF comes from the
observation that defective SFFV can "function" in a fibroblast test system to
directly interfere with MuLV-induced XC plaque formation in NIH Swiss and
BALB/c cells . SFFV interference is a heat-labile property directly associated
with the defective virus particles (7) . After this apparent detection of SFFV
function and possible infectivity for MEF, I set out to determine ifSFFV could
productively infect NIH Swiss cells . Approximately 2 x 10 5 Swiss cells contained938 FRIEND VIRUS COMPLEX (SFFV-LLV) IN VITRO
in a 75-cm' plastic T-flask were DEAE-dextran-treated for 1h. This culture was
next exposed to 5 x 104 FFU of Friend SFFV as contained in 5 ml of fresh
medium . This preparation of FV complex is NB-tropic and the inoculum con-
tained approximately 8 .4 x 105 PFU of NB-tropic LLV-F . After an adsorption
period of 1 h, an additional 10 ml of fresh medium was added to the flask. Media
was subsequently changed every 24 h for 5 days and assayed for the presence of
infectious SFFV as described in Materials and Methods . A small quantity of
detectable infectious SFFV remained in the media sample on day 1, and may
represent unadsorbed SFFV from the original inoculum . After 7 days of culture,
the Swiss cells exposed to FV complex (Swiss-FV cells) were trypsinized and 105
cells were passaged into a new T-flask. 24 h before this and each subsequent
passage, the cells were rinsed with phosphate-buffered saline (PBS) and 10 ml of
fresh media was added . All such samples were assayed for the presence of
infectious SFFV released into the media over the 24-h period . It is possible to
express the amount of infectious SFFV present in these 10-ml media samples as
SFFV recovered per 106 Swiss-FV cells since the cells were removed from the T-
flask by trypsinization and counted using a Coulter cell counter at the time of
media collection . The results presented in Fig. 1 show that <100 FFU of
detectable SFFV were recovered per 106 Swiss-FV cells between days 7-20,
while approximately 10 4 FFU of SFFV were recovered per 10 6 cells on day 28
with maximum titers recovered after 50 days . This time represents the 7th
subculture of Swiss-FV cells . The total amount of infectious SFFV recovered on
and after day 28 exceeds the titer of the original SFFV inoculum by sixfold,
indicating that Friend SFFV is truly replicating . Swiss-FV cells have now been
passaged at weekly intervals for 25 mo and continue to produce ?104 FFU of
SFFV per 106 cells .
Electron microscopic observations of Swiss-FV cells prepared from concen-
trated culture media have revealed numerous type-C virus particles in cyto-
plasmic vesicles, budding from the cytoplasmic membrane, and free in the
extracellular space. No evidence of mycoplasma growth was present in control
or infected culture media .
Immunostimulatory (Mitogenic) Properties of In Vitro-Derived FV com-
plex . The proliferative responses that occur in vitro after exposure of murine
lymphocytes to nonspecific agents such as phytohemagglutinin (PHA) and
concanavalin A (Con A) have been shown to be directly suppressed in vitro by
RV complex (21), and FV complex (Kumar and Eckner, unpublished observa-
tions), both of which contain SFFV and LLV, and by the Moloney (MoILV) and
Gross (GLV) strains of MuLV (22) . To determine if in vitro-derivedFV complex
(i.e ., FV-TC preparations) could also suppress the proliferative response of
murineT cells to Con A, BALB/c thymocytes were cultured in the presence or
absence of T-cell mitogen with and without various dilutions (80-100 FFU) of
several FV-TC preparations . All FV-TC preparations tested failed to suppress
the response ofBALB/c thymus cells to ConA. FV harvested at the 6th and 9th
subcultures of Swiss-FV cells (FV-TC6 and FV-TC9, respectively) neither sup-
pressed nor stimulated . However, FV complex derived from the 12th (FV-TC12)
and subsequent subcultures was mitogenic for BALB/c thymus cells in vitro
(Fig . 1) . To further investigate the mitogenic nature of FV-TC preparations,N 104
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FIG. 1. Replication of Friend SFFV in NIH Swiss mouse embryo fibroblasts. The bar
graph beneath thecorresponding in vitro-derived SFFV titerestimatesin FFU summarizes
the results o£ experiments designed to determine the ability of several different FV-TC
preparations to act as a nonspecific mitogen for BALB/c thymus cells.
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virus from the 18th subculture of Swiss-FV cells (FV-TC18) was prepared and
assayed for the presence of both SFFV and LLV-F. As shown in Table 1, the FV-
TC18 preparation was mitogenic for BALB/c thymus cells at all virus doses used
ranging from 80 to <1.0 FFU of SFFV per microtest plate well. This result, as
well as the results of experiments using LLV isolated from FV-TC stock,
indicate that in vitro-derived LLV-F is of itself fully mitogenic at doses as low as
10 PFU per microtest plate well (Table 1, Exp. 1). Further, the mitogenicity of
LLV without SFFV present is virtually identical to that observed when SFFV
was present, suggesting that SFFV does not directly contribute to this response .
When both FV-TC18 and Con A were added to the cultures, two different
responses were observed which were dependent upon the virus dose. The highest
FV-TC dose (80 FFU/10,000 PFU) diminished the Con A response by approxi-
mately 3,500 cpm . This may be due to mitogen overload in the test system since
all other FV-TC18 doses used with Con A resulted in PH]thymidine incorpora-
tion values in cpm which were approximately additive when compared to the
FV-TC18 and Con A controls (Table I, Exp. 1) . The mitogenicity of in vitro-
derived FV complex is both a heat-labile and UV-sensitive property of the virus
(Table 1, Exp. 2), as is the immunosuppressive property of in vivo-derived LLV-
F . Further, FV mitogenic properties are directly associated with the virus
particles since the immunostimulatory activity bands in sucrose and is present
only if XC plaque-forming activity is also present. Finally, supernatant fluids
from uninfected NIH Swiss MEF cultures are not mitogenic in this test system
(Table I, Exp. 2).940
TABLE I
Effect of In Vitro-Derived FV Complex and LLV Only on the Proliferative Response
BALBlc Thymus Cells
"Normal" NIH Swiss culture
fluid
Exp . 3
None ; cells only
None ; cells + ConA
Cells + FV-TC passaged once in
vivo
FRIEND VIRUS COMPLEX (SFFV-LLV) IN VITRO
Virus dose* [3H]Thymidine incorporation (cpm)$
200(1.3)
- 414
-
￿
13,085 (32)
80/10'
￿
259 (0.62)
￿
339 (1.55)
Of
* Virus titer estimates for SFFV were determined using the spleen focus assay in permissive
BALB/c mice, while LLV titer estimates were determined in vitro (BALB/c MEF) using the XC
plaque assay as described (20) .
$ Afteran incubation period of48 h, each culture (i .e ., each microtest plate well) received 0.5 tkCi
of [3H]thymidine . After 24 h of further incubation (optimum response), the cultures were
harvested as described in Materials and Methods . The incorporation of ['H]thymidine was
measured in a liquid scintillation counter and the blastogenic (proliferative) response of murine
thymocytes was expressed in cpm .
FV preparation SFFV (FFU/well)
LLV (PFU/well)
Control
(BI)§
+ FV
(BI)
+ FV and
ConA
(BI)
Exp 1
None ; cells only - 225 - -
None ; cells + Con A - 10,780 (48) - -
Cells + in vitro-grown SFFV- 80/10" - 23,370 (104) 7,310 (32)
LLV (FV-TC18)
8/10' - 11,300 (50) 17,500 (78)
0.8/101 - 7,580 (34) 14,700 (65)
0.08/10 - 8,940 (40) 16,100 (72)
Cells + in vitro-grown LLV -/103 - 12,500 (56)
_~10 1 - 7,900 (35)
-/10 - 7,050 (31)
Exp . 2
None ; cells only - 154 -
None ; cells + Con A - 13,890 (90) -
Cells + FV-TC18 80/10" 18,720 (121)
8/10 3 8,500 (55)
0.8/101 5,740 (37)
Heat-inactivated FV-TC18 80/10' 230 (1.5)
(56°C for 60 min)
UV-inactivated FV-TC18 80/10' 276 (1.8)
Sucrose gradient-purified
FV-TC18
Sample pool (1.12-1 .14 g/ml) <10/<10 500 (3.2)
(1.15-1.17 g/ml) 10/500 8,060 (52)
(1.18-1 .20 g/ml) «10/=10 2000.3)
Resuspended FV-TC18 pellet 10/1,200 9,060 (59)E
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FIG. 2 .
￿
Dose-response relationships of in vitro-derived Friend spleen focus-forming virus
(FV-TC18), as titrated in N-(Fv-1"") and B- (Fv-1°°) type mice .
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One in vivo passage of FV-TC18 resulted in the total loss of the mitogenic
property with the reappearance ofimmunosuppressive properties (Table I, Exp .
3) . This result demonstrates a clear association between in vivo growth of FV
and its ability to suppress mouse thymocytes, and suggests that FV complex
(SFFV-LLV) is not inherently immunosuppressive . While the mechanism of this
interconversion between immunostimulatory and suppressive virus is un-
known, both virus markers appear to be dependent upon the presence of infec-
tiousFV .
Host Range and Leukemogenicity (Focus Formation) of In Vitro-Derived
SFFV . The NB-tropic preparation ofFV complex used to infect theNIH Swiss
cells (as described above) contained fully leukemogenic SFFV and LLV-F. To
determine if the in vitro-derived FV complex (specifically the FV-TC18 prepara-
tion referred to here as FV-TC) expresses the same host range in vivo for focus
formation as the original preparation of FV complex used as source material,
several different strains of N-type (Fv-1 "") and B-type (Fv-1 °°) mice were inocu-
lated with serial dilutions of this high titer FV-TC preparation obtained as an
unconcentrated 24-h media harvest from the 18th subculture ofSwiss-FV cells .
As shown in Fig . 2, this FV-TC preparation effectively induced spleen foci in
§ Control cultures received either cells alone, or cells plus Con A only . The doses of Con A used in
these experiments did not agglutinate FV since there was no reduction in the titer estimate of
FV suspensions exposed to ConA. The blastogenic index (BI) is defined as a ratio of the result of
the test culture with Con A, FV-TC, or both Con A and FV-TC added, to the corresponding
control (cells only) for mitogen response .
J1 StockFV-TC18(an in vitro-derivedSFFV-LLV complex) was diluted 1 :10 and0.5 ml was injected
intravenously in agroup ofsix4-wk old BALB/c mice .9days later, theenlarged erythroleukemic
spleens were removed, A 20% (wt/vol) cell-free extract of leukemic tissue was prepared and
stored at -196°C .942
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both N- and B-type mice . Only the SFFV-resistant Fv-2''' (17) mice C57BL/6,
C58, and ABT/Ha (16) were totally resistant to SFFV contained in FV-TC
indicating that this virus is not able to overcome Fv-2 genetic resistance . From
this data it can be concluded thatFV-TC is NB-tropic for in vivo focus formation .
Since SFFV-induced focus formation is "helper controlled", that is, directly
dependent upon the ability of associated MuLV to provide a helper function for
late stages in SFFV synthesis (1), it can be assumed that a high titer helper
virus (presumably LLV) is present and functioning in FV-TC preparations .
Leukemogenicity of In Vitro-Derived Friend LLV .
￿
A high titer XC plaque-
forming virus is present in FV-TC stocks in excess over SFFV (>_106 PFU/ml as
detected in BALB/c cells), and can be isolated free of detectable SFFV via
endpoint dilution techniques . To determine ifthis virus was leukemogenic when
administered to susceptible newborn BALB/c mice, an experimental protocol
was designed as follows : inocula ofthe same FV-TC preparation used in the host
range study described above were prepared as serial 10-fold dilutions ranging
from 1 :100 to 1 :10' . Each newbornBALB/c mouse received 0 .1 ml of a given virus
dilution intraperitoneally . All mice were subsequently observed for onset of
splenomegaly and leukemia . As a control, a preparation of in vivo-derived NB-
tropic FV complex was similarly diluted and inoculated intraperitoneally into
groups ofnewborn BALB/c mice . As shown in Table II, the infectious SFFV dose
contained in the FV-TC inocula ranged from 40 FFU to <1 .0 FFU, while at each
virus dilution, mice received a substantially higher infectious dose ofLLV, the
presumed plaque-forming virus present in all FV-TC preparations together with
SFFV and present beyond the SFFV endpoint . This same relationship holds true
for the in vivo-derived SFFV-LLV preparation . All LLV(PFU)/SFFV(FFU) ra-
tios were determined utilizing a dose-response technique (7) . Soon after the
initiation of this experiment, mice given the highest SFFV doses (as contained
in FV-TC preparations and in vivo-grown FV complex) began to die of erythroid
leukemia (typical Friend disease) . Further, infectious SFFV could be readily
obtained from the spleen extracts of all such animals . After an average latent
period of 70 days, all mice which had received approximately 1 .0 FFU of SFFV
(0.1-1.0 FFU) were dead and were shown to have had erythroid leukemia,
polycythemia, and SFFV viremia (Table II) . In contrast, most mice receiving
<0.1 FFU of either in vitro- or in vivo-derived SFFV eventually succumbed to a
lymphoid disease, with an associated anemia and high peripheral white blood
cell counts . The liver sinusoids were heavily infiltrated with leukemic cells (Fig .
3 a) . The lymph nodes and bone marrow contained leukemic infiltrates or were
completely replaced by leukemic cells . However, the thymus was not involved .
The spleens revealed either extensive myeloid metaplasia or complete replace-
ment of normal hematopoietic elements with leukemic cells (Fig . 3 b) . The
cytological appearance of the leukemic cells varied between very poorly differen-
tiated lymphoblasts to well-differentiated lymphocytes and the peripheral white
blood cell counts varied between 80,000 and 100,000 cells/mm' in leukemic mice .
This is typical of Friend LLV-induced leukemia . In addition, no detectable
SFFV was recovered from any of these animals while >10' PFU of MuLV
(presumably LLV-F) was easily detected . In experiments not presented here, it
has been shown that the XC plaque-forming virus recovered from mice origi-TABLE 11
Pathogenicity ofIn Vitro- andIn Vivo-DerivedFV Complex in Newborn BALBIc Mice
ROBERT J . ECKNER
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Virus dose*
￿
Histopathology of leukemia
induced Virus recovery§
NT = not tested . Since SFFV is known to interfere with LLV plaque formation in the XC test
(Eckner et al ., 1975), all leukemic spleen extracts known to containSFFV were not assayed for
the presence ofLLV using this test.
* Both in vitro- and in vivo-derivedFV complex were assayed for thepresence of infectious SFFV
using the spleen focus assayand for the presence ofLLVusing theXC plaque assay as described
in Experimental Procedures . SFFV and LLV titer estimates are expressed in FFU and PFU,
respectively .
$ The form of leukemia induced was confirmed histologically using spleen, liver, and lymphnode
tissue sections as well as peripheral blood smear preparations . Those mice exhibiting erythroid
disease were found to be polycythemic with hematocrits ranging from 60 to 80%, while those
mice presenting with lymphatic leukemia had hematocrits ranging from 8 to 19% .
§ Thespleensfrom all leukemic mice exceeded a weight of 1 g . From each individual spleen, a 20%
wt/vol extractwas prepared and the cell-free supernatant fluid was assayed for the presence of
SFFV, LLV, or both, as described above . Although each animal was tested separately for SFFV
and LLV, the SFFV andLLV titer estimates presented here represent theaverage titer estimate
for all positive leukemic mice in each group .
nally inoculated with either FV-TC or in vivo-grown FV complex can provide a
helper function (24) to defective SFFV in vivo and is neutralized by type-specific
murine antisera directed against LLV-F .
Discussion
The studies presented in this paper show for the first time extensive growth of
Friend SFFV in a nonhematopoietic target cell . Unlike other strains of MuLV
which have been successfully grown in monolayer cultures ofMEF for extended
periods of time and have become attenuated (8-13), the defective SFFV compo-
nent of the in vitro-derived FV complex, and the LLV-F helper virus did not
decrease in leukemogenic potential (Table II) .
Inoculum SFFV (FFU/_animal)
LLV (PFU/animal) Typef
Avg .
latent
period
Frequency
(no .
leukemic/
no . inocu-
lated)
SFFV LLV
days FFU/ml PFU/ml
In Vitro-grown 40.00/2,000 Ery 12 7/7 >103 NT
SFFV-LLV 4.00/200 Ery 27 7/7 >103 NT
0.40/20 Ery 70 7/7 4 x 10 3 NT
0.04/2 Lym 86 3/5 0 2.6 x 10 5
0.004/0 .2 Lym 102 2/6 0 8.0 x 10 5
In Vivo-grown 5.00/300 Ery 47 7/7 >103 NT
SFFV-LLV 0.50/30 Ery 60 7/7 3 x 103 NT
0.05/3 Lym 194 4/6 0 10 ,
0.005/0.03 Lym 124 3/7 0 9 x 10 4
None 0/0 None - 0/5 0 0944ROBERT J . ECKNER
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Yoshikura et al . (12)haveshown that nonleukemogenic strains ofFV (presum-
ably LLV-F only) may be propagated in vitro and are infectious for MEF
cultures based on their ability to interfere with infection by murine sarcoma
virus (MSV), and to act as a helper for defective MSV . In a similar fashion, the
LLV-F obtained from Swiss-FV cells acts as a helper for both defective SFFV
and MSV .
A basic question remains unanswered : why is LLV-F, unlike other fibro-
blastic cell-grown MuLV's, fully leukemogenic after extended growth in NIH
Swiss cells? This observation may be due to the continued presence of fully
leukemogenic SFFV in this culture system . There may be an intracellular viral
interaction between SFFV and LLV-F in nonhematopoietic tissue which allows
for the persistence of oncogenic potential in both viruses . An interdependency
between these two viruses for replicative events has been described (1, 18, 25),
and it is not unreasonable to speculate that complementation of defective and
helper virus functions occurs at the level of viral-induced transformation of
susceptible target cells as well . A recent report by Greenberger et al . (26)
suggests that the endogenous "mouse-tropic" type-C virus of C58 (C58-MuLV)
and BALB/c MEF (BALB :virus-1) are able to induce lymphatic leukemia and
myeloid metaplasia, respectively, when inoculated into newborn NIH Swiss
mice . This in vivo biological function was presumably detected in the absence of
other infectious or induced MuLV's . However, it is possible that the appearance
ofleukemia in C58-MuLV-inoculated mice may be only partially related to the
presence of this virus since only 14% of such inoculated mice developed spleno-
megaly 15 mo after infection . The possible "association" between C58-MuLV
infection and leukemia induction might be further defined by comparing the
antigenic markers of the leukemic cells recovered to those of the original C58-
MuLV as well as to any infectious virus present in or on leukemic cells . It has
also been suggested that immunologically activated or induced MuLV's are
leukemogenic (27-29) . Such spleen cell-derived MuLV genomes (i .e ., mouse-
tropic XC plaque formers) are most certainly leukemia-associated and may be of
etiological importance since 70% of virus-infected mice have been shown to
develop lymphoreticular tumors (27) .
The availability of in vitro (MEF)-derived FV complex will allow the produc-
tion of large quantities of purified virus for use in studies concerning the
biophysical and biochemical properties of both SFFV and LLV . Further, it may
be possible to determine what material is perhaps nonspecifically packaged into
both SFFV and LLV-F particles due to their intimate association with erythroid
cells in vivo . It has already been shown by Ikawa et al . (30) that host globin
messenger RNA's are incorporated into FV particles . The observation that FV-
TC is mitogenic for some mouse lymphoid cells has been extended to show that
only cells contained in the thymus respond to FV-TC . Spleen and lymph node
FIG . 3 .
￿
Histopathology ofleukemia induced in BALB/c mice by in vitro-derivedLLV-F . (a)
A low power view of the liver to demonstrate the infiltrate of leukemia cells, principally
about the central veins, but also within the hepatic sinusoids . (H & E, x 100) . (b) The large
leukemic cellswith large vesicular nuclei and prominent nucleoli flood the splenic pulp and
virtually replace the smallerlymphocytes(seen as small dark interspersed forms) . (H & E,
x 200) .946
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suspensions do not contain FV-TC-responsive cells . This virus-cell interaction
which results in the proliferative response ofsome lymphoid tissue may allow us
to critically investigate the role of various lymphocyte subpopulations in surveil-
lance against mouse leukemia .
Summary
Exposure of NIH Swiss mouse embryo fibroblasts (MEF) to infectious Friend
virus (FV) complex [containing defective spleen focus-forming virus (SFFV) and
endogenous NB-tropic leukemia-inducing helper virus (LLV-F)] resulted in the
productive infection of these cells by both SFFV and LLV-F . Stocks of SFFV
derived after extensive growth in this Swiss MEF cell culture system are fully
leukemogenic in adult mice for the induction of erythroleukemia and spleen
foci . In addition, in vitro-derived LLV-F, when isolated free of SFFV, is fully
leukemogenic for the induction oflymphatic leukemia when inoculated into sus-
ceptible newborn BALB/c mice . The host range of in vitro-derived FV complex
(i.e ., FV-TC) for focus formation in vivo is NB-tropic . Unlike in vivo-derivedFV
complex, FV-TC does not suppress the responsiveness ofmurine thymocytes to
concanavalin A (Con A) in vitro . Rather, FV-TC acts as a mitogen to nonspecifi-
cally stimulate the proliferation of BALB/c thymocytes . The mitogenicity of in
vitro-derived FV complex is directly associated with the presence of type-C virus
particles, is a heat-labile and UV-sensitive property of the virus, and may be
primarily due to LLV since equivalent amounts of LLV with or without SFFV
present are equally mitogenic . One in vivo passage of FV-TC resulted in the
total loss of this mitogenic property with the reappearance of full immunosup-
pressive properties . This result demonstrates a clear association between in vivo
growth of FV and its ability to suppress mouse thymocytes, and suggests that
FV complex (SFFV-LLV) is not inherently immunosuppressive for these cells .
While the mechanism of this interconversion between immunostimulatory and
fully suppressive virus is unknown, both virus markers appear to be dependent
upon the presence of infectious FV .
Addendum . Dr . A . Axelrad (University of Toronto, Ontario, Canada) has recently
obtained an N-tropic Friend SFFV from an adherent, nonerythroid cell line established
from the spleen tissue of FV-infected mice . Although of hematopoietic origin, these cells
represent another nonerythroid monolayer culture system producing infectious SFFV
(personal communication) .
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